Most significantly, our data shows for the first time that the concomitant over expression of IGFBP2 and β-catenin in breast cancer is associated with increased incidence of lymph node metastasis. This evidence concerns the gene IGFBP2 and metastatic malignant neoplasm in the lymph nodes.